Reishi
A medicinal mushroom (Ganoderma lucidum) used as a bitter, earthy powdered fruiting body or extract in ‘functional’ foods and supplements for immune support.
Should I eat Reishi?
Reishi is a traditional medicinal mushroom with modern extracts that may modulate immunity, but typical food doses are small and benefits are uncertain. If you use it, watch for drug interactions (especially blood thinners) and rare liver effects, and avoid high doses unless guided by a clinician.
Summary
Reishi brings beta‑glucans and triterpenes that may influence immune signaling, with antioxidant and possible prebiotic effects mostly shown in lab studies. Human trials show low‑certainty benefits only as adjuncts to standard care and no survival benefit in cancer. Safety is generally acceptable at modest intakes, but interactions with anticoagulants/antiplatelets and rare liver injury reports warrant caution. Extracts are processed and vary widely, and regulatory status differs by form, so product quality and dosing matter. For most people, small amounts in foods are unlikely to produce measurable health effects.
Key Research Points
Overview
What is it?
Why is it used?
Origin
Reishi (lingzhi) is documented in Chinese materia medica for more than 2,000 years, symbolizing longevity and ‘spirit plant’ status. Cultivation scaled in the late 20th century (China, Japan), enabling hot-water/ethanol extracts standardized to polysaccharides (β-glucans) or triterpenoids to appear in global supplements and, more recently, in bars and beverages.
Process: Hot-water or ethanol extraction; dry & mill
Steps
Chemicals
Research & Safety
Potential Concerns
The biggest practical risk is drug interaction: reishi may raise bleeding risk with anticoagulants and antiplatelet agents. Rare liver injury has been reported, so people with liver disease or new liver symptoms should avoid it and consult a clinician. Extracts are highly processed (hot water/ethanol) and vary by species part (fruiting body vs mycelium), dose, and standardization; side effects appear more common at higher or prolonged doses. Regulatory status differs by form: specific mycelial beta‑glucans are GRAS in the U.S., while dehydrated mycelium is a Novel Food in the EU.
Potential Benefits
Reishi supplies beta‑glucans and triterpenes that may modulate immune signaling; human evidence remains limited and low certainty. A Cochrane review suggests it may help as an adjunct to standard cancer therapy but does not improve survival, so it should not replace medical care. It shows antioxidant activity and contains compounds like ergosterol (a vitamin D2 precursor), though typical food inclusions are small and unlikely to move lab values. Early research suggests its polysaccharides may act as prebiotics, but convincing human data are still needed.
Digestive Effects
Most people tolerate low food‑level amounts, but concentrated extracts can cause nausea, diarrhea, or dizziness. Reported side effects are more common at multi‑gram extract doses or with long‑term high intake. People with sensitive digestion or IBS may react to extracts; start with a low dose to test tolerance and discontinue if symptoms persist. If you develop severe or persistent GI symptoms, stop use and seek medical advice.
Limit Consumption
Infants and young children: not recommended due to limited safety data. Pregnancy and breastfeeding: avoid high‑dose use because human data are insufficient. People on blood thinners or antiplatelets, or those with planned surgery, should avoid high doses and consult a clinician due to bleeding risk (MSKCC). Individuals with liver disease or new liver symptoms should avoid reishi, given rare hepatotoxicity signals (NIH LiverTox). Those on antihypertensive or blood‑sugar–lowering medicines should discuss use with their clinician, as interactions are possible per integrative medicine monographs.
Fact Sheet
Regulatory Status
ESG & Sustainability
Allergens and Diet
Natural Alternatives
Maitake
Shiitake
Turkey tail
Citations
GRN 413 – Beta glucans derived from Ganoderma lucidum mycelium
2012-01-11Super Beta Glucan, Inc. • FDA GRAS Notice Inventory
Ganoderma lucidum dehydrated mycelium powder – Novel Food status
2019-10-29AESA/EC • European Commission
Ganoderma lucidum (Reishi mushroom) for cancer treatment
2016-10-24Jin X., et al. • Cochrane Database of Systematic Reviews
Lingzhi, Reishi
2024-10-05National Institute of Diabetes and Digestive and Kidney Diseases • LiverTox (NIH/NIDDK)
Cholestatic liver injury from Ganoderma lucidum coffee extract
2022-08-10Tay YZ., et al. • Annals of Medicine
Reishi Mushroom
2023-02-09MSKCC • MSKCC Integrative Medicine
Ganoderma lucidum—From Ancient Remedies to Modern Applications
2025-05-08Plosca MP., et al. • Antioxidants (MDPI)
Addition of Reishi and Lion’s Mane Mushroom Powder to Pasta
2023-03-08Szydłowska-Tutaj M., et al. • Antioxidants (MDPI)
Significance of Medicinal Mushrooms in Integrative Oncology
2020-10-13Jeitler M., et al. • Frontiers in Pharmacology
Ganoderma spp. polysaccharides are potential prebiotics
2022-08-18Zheng M., et al. • Critical Reviews in Food Science and Nutrition